Arteemether 80mg + Lumefantrine 480 mg Tablets

First ACT approved by USFDA

In the Management of Uncomplicated Malaria and Resistant cases of both

Chloroquin & Sulphadoxin-Pyrimethamine Combinations

NEW WHO MALARIA TREATMENT GUIDELINES

  • Must be treated with ACT and not with any other monotherapy.
  • Patients with body weight > 35 kg must be given for at least 3 days B.I.D.for an optimum effect of 6 dose regimen.

 

ARTEEMETHER-LUMEFANTRINE RECOMMENDATIONS FOR UNCOMPLICATED VIVEX MALARIA2

  • ACT has been adopted as the first line treatment for Falciparum Malaria, ¡t may
    also be used for P. vivex malaria in combination with Primaquine for radical cure.

 

ARTEEMETHER-LUMEFANTRINE HAS 75% HIGHER CURE RATE, 24 HRS FASTER RAPID PARASITE CLEARANCES AND 9 HRS HIGHER RESOLUTION OF FEVER THAN CHLOROQUIN3

 

ARTEEMETHER — LUMEFANTRINE

  • Act as Potent Blood Schizontocides
  • Interferes With Heam Polymerisation.
  • Inhibits nucleic acid and protien synthesis within the malarial parasite.
  • Lesser chance to develop resistance.
  • Safe & well tolerated compared to other ACT.

 

ANTI MALARIAL - ATINATE PLUS

© Copyright 2012 All Rights Reserved                                                                                                                                                                                                                                                                              Designed byKrisnela